Cargando…
Strontium ranelate causes osteophytes overgrowth in a model of early phase osteoarthritis
BACKGROUND: Osteoarthritis (OA) involves cartilage changes as well as modifications of subchondral bone and synovial tissues. Strontium ranelate (SR), an anti-osteoporosis compound, which is currently in phase III clinical trial for treatment of OA. Evidences suggest that SR preferably deposited in...
Autores principales: | Chu, Jian-Guo, Dai, Mu-Wei, Wang, Yu, Tian, Fa-Ming, Song, Hui-Ping, Xiao, Ya-Ping, Shao, Li-Tao, Zhang, Ying-Ze, Zhang, Liu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303224/ https://www.ncbi.nlm.nih.gov/pubmed/28187731 http://dx.doi.org/10.1186/s12891-017-1399-2 |
Ejemplares similares
-
Effect of strontium ranelate on pain behavior in an experimental model of osteoarthritis
por: Rodrigues, T.A., et al.
Publicado: (2017) -
Chondroprotective effect of melatonin and strontium ranelate in animal model of osteoarthritis
por: Paulino Silva, Kássya Mycaela, et al.
Publicado: (2021) -
Prophylactic and Therapeutic Use of Strontium Ranelate Reduces the Progression of Experimental Osteoarthritis
por: Rodrigues, Thiago A., et al.
Publicado: (2018) -
Polymeric strontium ranelate nonahydrate
por: Stahl, Kenny, et al.
Publicado: (2011) -
Cardiac concerns associated with strontium ranelate
por: Reginster, Jean-Yves
Publicado: (2014)